New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues DUKE UNIVERSITY A CLOSE-UP VIEW OF A HANDFUL OF NANOSTARS USED TO CREATE A NEW TYPE OF CANCER DIAGNOSTIC. view more CREDIT: TUAN VO-DINH, DUKE UNIVERSITY Biomedical engineers at Duke University have engineered a method for simultaneously detecting the presence of multiple...
By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked satellite tumors and distant cancerous cells, completely curing two mice and effectively vaccinating one against the disease. The results appeared online in Scientific Reports on August...
